Skip to main content

Theratechnologies Inc(THTX-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Theratechnologies Inc

2015 Peel Street 11th Floor
MONTREAL A8 H3A 1T8 CAN
P: 438-315-6607
F: 514-331-9691
http://www.theratech.com

Sectors & Indices

Sector
Industry
Employees

Profile

Theratechnologies, Inc. is a pharmaceutical company focusing on the development of therapeutic peptide products with an emphasis on growth-hormone releasing factor peptides. It's main product EGRIFTA is used for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy which is marketed primarily in the United States, Latin America, Africa, the Middle East, Europe, Russia, South Korea, Taiwan, and Thailand. Theratechnologies, Inc. is headquartered in Montreal, Canada.

Key Executives

NameTitle
Christian MarsolaisChief Medical Officer/Senior VP
Marie-Noel ColussiVice President, Divisional
Jocelyn LafondGeneral Counsel/Secretary
Philippe DubucCFO/Senior VP
Paul LevesqueCEO/Director/President
Andre DuprasVice President, Divisional
John LeasureOther Corporate Officer

More from The Globe